The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/31025
StudyName: Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755
Date of export from the portal: 02.07.2020
Copyright Holder: see clinicaltrials.gov
Date of Upload / last change: 12.07.2018
License: Creative Commons BY 4.0

----

Description: 
Study ID: 104505
Clinical Study ID: BEX104505
Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology
Patient Level Data: Study Listed on ClinicalStudyDataRequest.com
Clinicaltrials.gov Identifier: NCT00950755
Sponsor: GlaxoSmithKline
Collaborators: N/A
Phase: Phase 2
Study Recruitment Status: Completed
Generic Name: tositumomab
Trade Name: Bexxar
Study Indication: Lymphoma, Non-Hodgkin
